187 related articles for article (PubMed ID: 84091)
1. Differences in cell surface antigens of tumor metastases and those of the local tumor.
Fogel M; Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
3. Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum.
Fogel M; Segal S; Gorelik E; Feldman M
Int J Cancer; 1978 Sep; 22(3):329-34. PubMed ID: 81185
[TBL] [Abstract][Full Text] [Related]
4. Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells.
Schechter B; Treves AJ; Feldman M
J Natl Cancer Inst; 1976 May; 56(5):975-9. PubMed ID: 994207
[TBL] [Abstract][Full Text] [Related]
5. Differences in immunogenicity between the local tumor 3LL and its metastasis-derived line as detected by sensitization with antigen-fed macrophages.
Brodt P; Segal S
Invasion Metastasis; 1982; 2(3):185-96. PubMed ID: 7188394
[TBL] [Abstract][Full Text] [Related]
6. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
Gorelik E; Fogel M; Feldman M; Segal S
J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
[TBL] [Abstract][Full Text] [Related]
7. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
8. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
Hurwitz E; Schechter B; Arnon R; Sela M
Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
[TBL] [Abstract][Full Text] [Related]
9. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
10. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.
Vessière F; Georlette M; Warnier G; Leclerc JC; Van Pel A; Boon T
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):867-74. PubMed ID: 6185345
[TBL] [Abstract][Full Text] [Related]
13. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development.
Kurosawa S; Matsuzaki G; Harada M; Ando T; Nomoto K
Eur J Immunol; 1993 May; 23(5):1029-33. PubMed ID: 8477798
[TBL] [Abstract][Full Text] [Related]
14. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
15. Identification of a surface antigen, common to murine lung and Lewis lung carcinoma, by monoclonal antibody.
Hadas E; Hurwitz E; Eshhar Z
Int J Cancer; 1984 Mar; 33(3):369-74. PubMed ID: 6365802
[TBL] [Abstract][Full Text] [Related]
16. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
17. Etoposide induction of tumor immunity in Lewis lung cancer.
Slater LM; Stupecky M; Sweet P; Osann K; Eklof A; Arquilla ER
Cancer Chemother Pharmacol; 2001 Oct; 48(4):327-32. PubMed ID: 11710634
[TBL] [Abstract][Full Text] [Related]
18. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
Gold JE; Osband ME
Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
[TBL] [Abstract][Full Text] [Related]
19. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
Isakov N; Segal S; Hollander N; Feldman M
Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
[TBL] [Abstract][Full Text] [Related]
20. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.
Carnaud C; Hoch B; Trainin N
J Natl Cancer Inst; 1974 Feb; 52(2):395-9. PubMed ID: 4816002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
